From: PRECISE — pregabalin in addition to usual care: statistical analysis plan
Pregabalin (n = xxx) | Placebo (n = xxx) | |
---|---|---|
Self-reported daily dose (mg/day) | ||
Week 1 | xxx.x (xxx.x to xxx.x), n | xxx.x (xxx.x to xxx.x), n |
Week 2 | xxx.x (xxx.x to xxx.x), n | xxx.x (xxx.x to xxx.x), n |
Week 3 | xxx.x (xxx.x to xxx.x), n | xxx.x (xxx.x to xxx.x), n |
Week 4 | xxx.x (xxx.x to xxx.x), n | xxx.x (xxx.x to xxx.x), n |
Week 5 | xxx.x (xxx.x to xxx.x), n | xxx.x (xxx.x to xxx.x), n |
Week 6 | xxx.x (xxx.x to xxx.x), n | xxx.x (xxx.x to xxx.x), n |
Week 7 | xxx.x (xxx.x to xxx.x), n | xxx.x (xxx.x to xxx.x), n |
Week 8 | xxx.x (xxx.x to xxx.x), n | xxx.x (xxx.x to xxx.x), n |
Participants returning study medicines | n/N (%) | n/N (%) |
Participants consuming ≥80 % prescribed dose | ||
Medication diary | n/N (%) | n/N (%) |
Returned medicine count | n/N (%) | n/N (%) |
Assessment of participant blinding | ||
Pregabalin | n/N (%) | n/N (%) |
Placebo | n/N (%) | n/N (%) |
Don’t know | n/N (%) | n/N (%) |
Treatment satisfaction | ||
Very dissatisfied | n/N (%) | n/N (%) |
Dissatisfied | n/N (%) | n/N (%) |
Neutral | n/N (%) | n/N (%) |
Satisfied | n/N (%) | n/N (%) |
Very satisfied | n/N (%) | n/N (%) |